Brief: Invex Therapeutics Gets Regulatory Approval For IIH EVOLVE In France
21/04/2023 02:10
April 21 (Reuters) - Invex Therapeutics Ltd IXC.AX :
* RECEIVES REGULATORY APPROVAL FOR IIH EVOLVE IN FRANCE
Source text for Eikon: ID:nASX1LhFdY
Further company coverage: IXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invex Therapeutics
See all newsBrief: Invex Therapeutics Requests Trading Halt
Brief: Invex Therapeutics Says Narelle Warren Resigns As CFO
Brief: Invex Therapeutics' Negotiations Discontinued With Neurological Disease Therapeutics Development Co
Australia's Invex Therapeutics falls as agreement talks fade
Brief: Invex Therapeutics Seeks Trading Halt